Supply of povidone iodine ointment 10%
Open · 11 days left Hong Kong SAR, China · Medicines
| Buyer | Hospital Authority, Hong Kong |
|---|---|
| Reference | HAHO(S)/T/26-D078 |
| Closing date | 11 November 2026, 12:00 noon Hong Kong time (UTC+8) |
| Products | Povidone iodine ointment 10%. Contract of up to 36 months, extendable by up to 24 months. |
| Notes | Hard-copy tender in duplicate, plus a CD-ROM, goes in the HA Head Office tender box. Goods must be registered in Hong Kong. One sealed sample in the original sales pack, registered with the Pharmacy and Poisons Board, is due at the Sample Unit before closing, plus a mock-up if needed. A 2% deposit (5% if required) and product liability insurance of at least USD 10m are required. Deadline moves to the next working day if typhoon signal 8 or a black rainstorm is in force. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in Hong Kong SAR, China
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Supply of linezolid 600 mg injection (Hong Kong SAR, China, 2 Nov)
- Supply of lapatinib 250 mg tablets (Hong Kong SAR, China, 11 Nov)
- Supply of mercaptopurine 50 mg tablets (Hong Kong SAR, China, 13 Nov)
- Supply of sodium chloride 0.9% infusion 250 ml (Hong Kong SAR, China, 11 Dec)
- Supply of medicines for opportunistic infections (Government of Kenya) (Kenya, 3 Nov)
- Nationwide supply and distribution of adalimumab (Argentina, 3 Nov)
